Cargando…
Comparable Intestinal and Hepatic First-Pass Effect of YL-IPA08 on the Bioavailability and Effective Brain Exposure, a Rapid Anti-PTSD and Anti-Depression Compound
YL-IPA08, exerting rapid antidepressant-like and anxiolytic-like effects on behaviors by translocator protein (TSPO) mediation, is a novel compound that has been discovered and developed at our institute. Fit-for-purpose pharmacokinetic properties is urgently needed to be discovered as early as poss...
Autores principales: | Gao, You, Yang, Chunmiao, Wang, Lingchao, Xiang, Yanan, Zhang, Wenpeng, Li, Yunfeng, Zhuang, Xiaomei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732531/ https://www.ncbi.nlm.nih.gov/pubmed/33328995 http://dx.doi.org/10.3389/fphar.2020.588127 |
Ejemplares similares
-
Translocator protein ligand, YL-IPA08, attenuates lipopolysaccharide-induced depression-like behavior by promoting neural regeneration
por: Zhang, Xiao-Ying, et al.
Publicado: (2018) -
IPA 2009 International Meeting (IPA Rio)
Publicado: (2009) -
A PBPK Model of Ternary Cyclodextrin Complex of ST-246 Was Built to Achieve a Reasonable IV Infusion Regimen for the Treatment of Human Severe Smallpox
por: Zhang, Zhiwei, et al.
Publicado: (2022) -
The Many Faces of IpaB
por: Picking, Wendy L., et al.
Publicado: (2016) -
PA01.08. An evaluation of a new anti-aids herbo-mineral compound (laa-1)
por: Shukla, Pushpendra, et al.
Publicado: (2012)